Pieris Pharmaceu (PIRS) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 37 253 sessions, December 13, 2023 to December 13, 2024
- Largest daily move
- +88.6% close of July 24, 2024
- 1-year change
- +21.4% closing prices, December 13, 2023 to December 13, 2024
- 5-year change
- -94.8% closing prices, December 13, 2019 to December 13, 2024
Company Description
Pieris Pharmaceu (NASDAQ: PIRS) is classified in the research and development in biotechnology industry within the Pharmaceutical Preparations sector and carries a market capitalization of $18.0M.
PIRS has gained 21.4% over the past year. The last closing price was $13.60.
This page collects what Stock Titan holds for PIRS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pieris Pharmaceu (PIRS) closed at $13.60 on December 13, 2024. Over the past 12 months, the price has gained 21.4%.
PIRS Metrics & Rankings
Price returns through December 13, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Pieris Pharmaceu has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, stock split, clinical trial, conferences, earnings. View all PIRS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PIRS Company Profile & Sector Positioning
Pieris Pharmaceu (PIRS) operates in the Research and Development in Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.